

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gamma-aminobutyric acid transport (GO:0015812) | 7.61410984 |
| 2 | otic vesicle formation (GO:0030916) | 6.95331510 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.30098777 |
| 4 | nonmotile primary cilium assembly (GO:0035058) | 5.03819132 |
| 5 | cellular biogenic amine catabolic process (GO:0042402) | 4.63633445 |
| 6 | amine catabolic process (GO:0009310) | 4.63633445 |
| 7 | establishment of mitochondrion localization (GO:0051654) | 4.43891940 |
| 8 | coenzyme catabolic process (GO:0009109) | 4.29894484 |
| 9 | nucleobase catabolic process (GO:0046113) | 4.06959090 |
| 10 | cornea development in camera-type eye (GO:0061303) | 4.04762416 |
| 11 | urinary tract smooth muscle contraction (GO:0014848) | 4.00320059 |
| 12 | respiratory system process (GO:0003016) | 3.99535222 |
| 13 | negative regulation of axonogenesis (GO:0050771) | 3.90113841 |
| 14 | response to muscle activity (GO:0014850) | 3.87022100 |
| 15 | resolution of meiotic recombination intermediates (GO:0000712) | 3.83707245 |
| 16 | axonal fasciculation (GO:0007413) | 3.78716765 |
| 17 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.67866120 |
| 18 | mitochondrion transport along microtubule (GO:0047497) | 3.67866120 |
| 19 | cell proliferation in forebrain (GO:0021846) | 3.52993092 |
| 20 | glycosphingolipid biosynthetic process (GO:0006688) | 3.52038678 |
| 21 | positive regulation of mitochondrial fission (GO:0090141) | 3.49319536 |
| 22 | negative regulation of telomere maintenance (GO:0032205) | 3.37669598 |
| 23 | glycine transport (GO:0015816) | 3.36290350 |
| 24 | protein-cofactor linkage (GO:0018065) | 3.35178992 |
| 25 | axon extension (GO:0048675) | 3.32523177 |
| 26 | regulation of cilium movement (GO:0003352) | 3.31282877 |
| 27 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26573416 |
| 28 | regulation of autophagic vacuole assembly (GO:2000785) | 3.24502335 |
| 29 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.20908511 |
| 30 | neuron recognition (GO:0008038) | 3.18620332 |
| 31 | oligosaccharide biosynthetic process (GO:0009312) | 3.15390582 |
| 32 | behavioral response to nicotine (GO:0035095) | 3.15386708 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.09064902 |
| 34 | retinal rod cell development (GO:0046548) | 3.07252276 |
| 35 | presynaptic membrane assembly (GO:0097105) | 3.03805199 |
| 36 | isoprenoid biosynthetic process (GO:0008299) | 3.02970549 |
| 37 | postsynaptic membrane organization (GO:0001941) | 3.02374130 |
| 38 | peroxisome fission (GO:0016559) | 3.01843206 |
| 39 | auditory behavior (GO:0031223) | 3.00396898 |
| 40 | DNA double-strand break processing (GO:0000729) | 2.95773832 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 2.92188489 |
| 42 | cilium morphogenesis (GO:0060271) | 2.88311146 |
| 43 | seminiferous tubule development (GO:0072520) | 2.86208377 |
| 44 | photoreceptor cell development (GO:0042461) | 2.85207724 |
| 45 | polyamine metabolic process (GO:0006595) | 2.84695006 |
| 46 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.83749993 |
| 47 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.83610159 |
| 48 | regulation of collateral sprouting (GO:0048670) | 2.83144057 |
| 49 | eye photoreceptor cell development (GO:0042462) | 2.83118095 |
| 50 | regulation of microtubule-based movement (GO:0060632) | 2.82448308 |
| 51 | cholesterol biosynthetic process (GO:0006695) | 2.80929622 |
| 52 | tachykinin receptor signaling pathway (GO:0007217) | 2.79623574 |
| 53 | neuromuscular synaptic transmission (GO:0007274) | 2.79186683 |
| 54 | negative regulation of response to food (GO:0032096) | 2.77650331 |
| 55 | negative regulation of appetite (GO:0032099) | 2.77650331 |
| 56 | tryptophan catabolic process (GO:0006569) | 2.74615462 |
| 57 | indole-containing compound catabolic process (GO:0042436) | 2.74615462 |
| 58 | indolalkylamine catabolic process (GO:0046218) | 2.74615462 |
| 59 | iron coordination entity transport (GO:1901678) | 2.74048980 |
| 60 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.73874606 |
| 61 | detection of light stimulus involved in visual perception (GO:0050908) | 2.73874606 |
| 62 | ribonucleoprotein complex disassembly (GO:0032988) | 2.73187321 |
| 63 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.71110194 |
| 64 | organelle disassembly (GO:1903008) | 2.69613151 |
| 65 | mitochondrion degradation (GO:0000422) | 2.68718691 |
| 66 | neuron projection extension (GO:1990138) | 2.67347929 |
| 67 | positive regulation of protein kinase C signaling (GO:0090037) | 2.67335806 |
| 68 | forebrain neuron differentiation (GO:0021879) | 2.67189269 |
| 69 | dicarboxylic acid catabolic process (GO:0043649) | 2.66421428 |
| 70 | activation of protein kinase B activity (GO:0032148) | 2.65464845 |
| 71 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.64460366 |
| 72 | cell migration in hindbrain (GO:0021535) | 2.57911146 |
| 73 | synapsis (GO:0007129) | 2.56310206 |
| 74 | neuronal action potential propagation (GO:0019227) | 2.54243555 |
| 75 | DNA replication initiation (GO:0006270) | 2.53653664 |
| 76 | presynaptic membrane organization (GO:0097090) | 2.53551603 |
| 77 | telomere maintenance via recombination (GO:0000722) | 2.52234993 |
| 78 | regulation of vacuole organization (GO:0044088) | 2.51577079 |
| 79 | mechanosensory behavior (GO:0007638) | 2.51248197 |
| 80 | anterograde axon cargo transport (GO:0008089) | 2.49017221 |
| 81 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.48629981 |
| 82 | protein localization to synapse (GO:0035418) | 2.47240170 |
| 83 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.46186778 |
| 84 | regulation of gene silencing by RNA (GO:0060966) | 2.43190477 |
| 85 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.43190477 |
| 86 | regulation of gene silencing by miRNA (GO:0060964) | 2.43190477 |
| 87 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.42090410 |
| 88 | secondary metabolite biosynthetic process (GO:0044550) | 2.41862974 |
| 89 | L-methionine salvage (GO:0071267) | 2.41668520 |
| 90 | L-methionine biosynthetic process (GO:0071265) | 2.41668520 |
| 91 | amino acid salvage (GO:0043102) | 2.41668520 |
| 92 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.41131981 |
| 93 | anterograde synaptic vesicle transport (GO:0048490) | 2.41018732 |
| 94 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.40751600 |
| 95 | membrane depolarization during action potential (GO:0086010) | 2.40741477 |
| 96 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.40529845 |
| 97 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.39934968 |
| 98 | sulfation (GO:0051923) | 2.37927876 |
| 99 | regulation of action potential (GO:0098900) | 2.37899340 |
| 100 | dopamine transport (GO:0015872) | 2.37056480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.10408718 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.92836885 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.38809986 |
| 4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.19709231 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.19171219 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.91649681 |
| 7 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.47689666 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.45329347 |
| 9 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.39158844 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.38808639 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.17046486 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.10889753 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.07769646 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.06566738 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.04628048 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00183360 |
| 17 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.98417064 |
| 18 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98417064 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.95127113 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.92753219 |
| 21 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.89899908 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.87797075 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.86657667 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.80122379 |
| 25 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.77492528 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.74629901 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.73441042 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.69981255 |
| 29 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.69818470 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.63696074 |
| 31 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.60378567 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.59934350 |
| 33 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.57719674 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57403009 |
| 35 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53227160 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.46049753 |
| 37 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.45952704 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.43938108 |
| 39 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43832099 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43724480 |
| 41 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43724480 |
| 42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.43559910 |
| 43 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.41883595 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38838906 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.36679739 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35131306 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34511629 |
| 48 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.34163298 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33729860 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33610395 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33047664 |
| 52 | NCOR_22424771_ChIP-Seq_293T_Human | 1.30231949 |
| 53 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.29820523 |
| 54 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.29820523 |
| 55 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.29612370 |
| 56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29582892 |
| 57 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.28809200 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26718560 |
| 59 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.26493181 |
| 60 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25448703 |
| 61 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.23803054 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21455557 |
| 63 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20873078 |
| 64 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.20642910 |
| 65 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.19113892 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18284353 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17214534 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16619069 |
| 69 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.15547844 |
| 70 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14310928 |
| 71 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14306282 |
| 72 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.13425515 |
| 73 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.12770461 |
| 74 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12711373 |
| 75 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.12339199 |
| 76 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.11205256 |
| 77 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09924798 |
| 78 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.09263446 |
| 79 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.06372553 |
| 80 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03310035 |
| 81 | AR_20517297_ChIP-Seq_VCAP_Human | 1.03267815 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02641693 |
| 83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98075714 |
| 84 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.97646057 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96757033 |
| 86 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96570567 |
| 87 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96485126 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96096620 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94699374 |
| 90 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.94585556 |
| 91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94434950 |
| 92 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93314497 |
| 93 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93074522 |
| 94 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92551118 |
| 95 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.92239510 |
| 96 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.91040214 |
| 97 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.90678904 |
| 98 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.88388130 |
| 99 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88379077 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86019341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004858_abnormal_nervous_system | 6.83852182 |
| 2 | MP0003122_maternal_imprinting | 3.11418299 |
| 3 | MP0004142_abnormal_muscle_tone | 3.07376737 |
| 4 | MP0001529_abnormal_vocalization | 2.91012026 |
| 5 | MP0005423_abnormal_somatic_nervous | 2.90986295 |
| 6 | MP0003136_yellow_coat_color | 2.62353832 |
| 7 | MP0009046_muscle_twitch | 2.45525408 |
| 8 | MP0001188_hyperpigmentation | 2.34549614 |
| 9 | MP0003880_abnormal_central_pattern | 2.24738144 |
| 10 | MP0003121_genomic_imprinting | 2.19997990 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.13435201 |
| 12 | MP0006276_abnormal_autonomic_nervous | 2.13196403 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.10169270 |
| 14 | MP0001984_abnormal_olfaction | 2.01871653 |
| 15 | MP0002272_abnormal_nervous_system | 1.78981886 |
| 16 | MP0000372_irregular_coat_pigmentation | 1.77916739 |
| 17 | MP0005394_taste/olfaction_phenotype | 1.74352966 |
| 18 | MP0005499_abnormal_olfactory_system | 1.74352966 |
| 19 | MP0003315_abnormal_perineum_morphology | 1.70650578 |
| 20 | MP0008789_abnormal_olfactory_epithelium | 1.70438543 |
| 21 | MP0002160_abnormal_reproductive_system | 1.66575668 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 1.65715698 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.63355174 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.62877556 |
| 25 | MP0002063_abnormal_learning/memory/cond | 1.52294833 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 1.47298153 |
| 27 | MP0003123_paternal_imprinting | 1.43077604 |
| 28 | MP0004885_abnormal_endolymph | 1.41316300 |
| 29 | MP0003868_abnormal_feces_composition | 1.38287722 |
| 30 | MP0003635_abnormal_synaptic_transmissio | 1.37511534 |
| 31 | MP0002184_abnormal_innervation | 1.37404291 |
| 32 | MP0006072_abnormal_retinal_apoptosis | 1.36475051 |
| 33 | MP0002938_white_spotting | 1.35530265 |
| 34 | MP0002928_abnormal_bile_duct | 1.32433086 |
| 35 | MP0008058_abnormal_DNA_repair | 1.31077297 |
| 36 | MP0004215_abnormal_myocardial_fiber | 1.28988070 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.27976854 |
| 38 | MP0000778_abnormal_nervous_system | 1.27752266 |
| 39 | MP0002139_abnormal_hepatobiliary_system | 1.27605895 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.27548561 |
| 41 | MP0000537_abnormal_urethra_morphology | 1.27152059 |
| 42 | MP0004924_abnormal_behavior | 1.26785073 |
| 43 | MP0005386_behavior/neurological_phenoty | 1.26785073 |
| 44 | MP0003879_abnormal_hair_cell | 1.26618792 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.26251892 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.25925106 |
| 47 | MP0009745_abnormal_behavioral_response | 1.24237918 |
| 48 | MP0004270_analgesia | 1.20733486 |
| 49 | MP0009697_abnormal_copulation | 1.18937871 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.18883128 |
| 51 | MP0002064_seizures | 1.17121290 |
| 52 | MP0005187_abnormal_penis_morphology | 1.16870037 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 1.14916368 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.11397178 |
| 55 | MP0002734_abnormal_mechanical_nocicepti | 1.11095228 |
| 56 | MP0004133_heterotaxia | 1.10916217 |
| 57 | MP0001440_abnormal_grooming_behavior | 1.10609991 |
| 58 | MP0001324_abnormal_eye_pigmentation | 1.10229625 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.09486468 |
| 60 | MP0003385_abnormal_body_wall | 1.08771198 |
| 61 | MP0002882_abnormal_neuron_morphology | 1.08647358 |
| 62 | MP0002067_abnormal_sensory_capabilities | 1.07075041 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 1.06660941 |
| 64 | MP0003828_pulmonary_edema | 1.06182542 |
| 65 | MP0005253_abnormal_eye_physiology | 1.04342392 |
| 66 | MP0002735_abnormal_chemical_nociception | 1.04048009 |
| 67 | MP0000749_muscle_degeneration | 1.02825553 |
| 68 | MP0003075_altered_response_to | 1.02321974 |
| 69 | MP0002752_abnormal_somatic_nervous | 1.00121610 |
| 70 | MP0001485_abnormal_pinna_reflex | 0.99115484 |
| 71 | MP0002733_abnormal_thermal_nociception | 0.97177640 |
| 72 | MP0002557_abnormal_social/conspecific_i | 0.96754703 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 0.95497099 |
| 74 | MP0001970_abnormal_pain_threshold | 0.94926358 |
| 75 | MP0003646_muscle_fatigue | 0.94162425 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.93670390 |
| 77 | MP0001486_abnormal_startle_reflex | 0.92242794 |
| 78 | MP0002295_abnormal_pulmonary_circulatio | 0.91936978 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.91905988 |
| 80 | MP0002066_abnormal_motor_capabilities/c | 0.89827806 |
| 81 | MP0004859_abnormal_synaptic_plasticity | 0.88973073 |
| 82 | MP0000955_abnormal_spinal_cord | 0.86203517 |
| 83 | MP0001502_abnormal_circadian_rhythm | 0.84129874 |
| 84 | MP0008877_abnormal_DNA_methylation | 0.82727044 |
| 85 | MP0006292_abnormal_olfactory_placode | 0.82229817 |
| 86 | MP0001905_abnormal_dopamine_level | 0.81664127 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.81486994 |
| 88 | MP0002736_abnormal_nociception_after | 0.79598981 |
| 89 | MP0005330_cardiomyopathy | 0.78395109 |
| 90 | MP0005645_abnormal_hypothalamus_physiol | 0.77833960 |
| 91 | MP0005360_urolithiasis | 0.76882832 |
| 92 | MP0002095_abnormal_skin_pigmentation | 0.73253324 |
| 93 | MP0004811_abnormal_neuron_physiology | 0.73239239 |
| 94 | MP0005389_reproductive_system_phenotype | 0.72706129 |
| 95 | MP0000538_abnormal_urinary_bladder | 0.72427972 |
| 96 | MP0005365_abnormal_bile_salt | 0.72206751 |
| 97 | MP0000026_abnormal_inner_ear | 0.71855844 |
| 98 | MP0002233_abnormal_nose_morphology | 0.69281544 |
| 99 | MP0001963_abnormal_hearing_physiology | 0.68129553 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 0.67906503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Failure to thrive in infancy (HP:0001531) | 5.97706675 |
| 2 | Abnormality of the labia minora (HP:0012880) | 5.11486194 |
| 3 | True hermaphroditism (HP:0010459) | 4.99852623 |
| 4 | Gait imbalance (HP:0002141) | 4.85833915 |
| 5 | Pancreatic fibrosis (HP:0100732) | 4.64410770 |
| 6 | Abnormal hair whorl (HP:0010721) | 4.41406715 |
| 7 | Congenital primary aphakia (HP:0007707) | 4.39458434 |
| 8 | Atonic seizures (HP:0010819) | 4.23498525 |
| 9 | Pancreatic cysts (HP:0001737) | 4.21743807 |
| 10 | Polyphagia (HP:0002591) | 4.15253111 |
| 11 | Medial flaring of the eyebrow (HP:0010747) | 4.07781916 |
| 12 | Nephrogenic diabetes insipidus (HP:0009806) | 4.02937339 |
| 13 | Poor coordination (HP:0002370) | 3.83368303 |
| 14 | Poor suck (HP:0002033) | 3.69607589 |
| 15 | Abnormality of midbrain morphology (HP:0002418) | 3.47685232 |
| 16 | Molar tooth sign on MRI (HP:0002419) | 3.47685232 |
| 17 | Vaginal atresia (HP:0000148) | 3.40080783 |
| 18 | Specific learning disability (HP:0001328) | 3.33922040 |
| 19 | Genital tract atresia (HP:0001827) | 3.33852877 |
| 20 | Cystic liver disease (HP:0006706) | 3.25060791 |
| 21 | Oligomenorrhea (HP:0000876) | 3.19130873 |
| 22 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 3.15906459 |
| 23 | Nephronophthisis (HP:0000090) | 3.09722064 |
| 24 | Sclerocornea (HP:0000647) | 3.02532556 |
| 25 | Rimmed vacuoles (HP:0003805) | 2.88015223 |
| 26 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.87814207 |
| 27 | Abnormal protein glycosylation (HP:0012346) | 2.87814207 |
| 28 | Abnormal glycosylation (HP:0012345) | 2.87814207 |
| 29 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.87814207 |
| 30 | Hip dysplasia (HP:0001385) | 2.83391034 |
| 31 | Absent/shortened dynein arms (HP:0200106) | 2.78494403 |
| 32 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.78494403 |
| 33 | Absence seizures (HP:0002121) | 2.74228010 |
| 34 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.72882080 |
| 35 | Febrile seizures (HP:0002373) | 2.68234902 |
| 36 | Epileptic encephalopathy (HP:0200134) | 2.66857434 |
| 37 | Limb dystonia (HP:0002451) | 2.65942955 |
| 38 | Pendular nystagmus (HP:0012043) | 2.63625292 |
| 39 | Anencephaly (HP:0002323) | 2.61998735 |
| 40 | Chronic hepatic failure (HP:0100626) | 2.61526886 |
| 41 | Male pseudohermaphroditism (HP:0000037) | 2.61225389 |
| 42 | Renal cortical cysts (HP:0000803) | 2.50552152 |
| 43 | Global brain atrophy (HP:0002283) | 2.47947261 |
| 44 | Postaxial foot polydactyly (HP:0001830) | 2.45316958 |
| 45 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.43349975 |
| 46 | Furrowed tongue (HP:0000221) | 2.43162956 |
| 47 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.39987120 |
| 48 | Urinary urgency (HP:0000012) | 2.37646304 |
| 49 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.32465777 |
| 50 | Astigmatism (HP:0000483) | 2.31332708 |
| 51 | Abnormality of the renal medulla (HP:0100957) | 2.27622814 |
| 52 | Nasal speech (HP:0001611) | 2.27598941 |
| 53 | Abnormal ciliary motility (HP:0012262) | 2.26863775 |
| 54 | Hyperglycinemia (HP:0002154) | 2.26466207 |
| 55 | Dialeptic seizures (HP:0011146) | 2.24289538 |
| 56 | Meckel diverticulum (HP:0002245) | 2.22776411 |
| 57 | Broad alveolar ridges (HP:0000187) | 2.19159776 |
| 58 | Focal motor seizures (HP:0011153) | 2.18050149 |
| 59 | Decreased testicular size (HP:0008734) | 2.13866604 |
| 60 | Abnormality of the ileum (HP:0001549) | 2.09896483 |
| 61 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.06633854 |
| 62 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.06633854 |
| 63 | Progressive cerebellar ataxia (HP:0002073) | 2.05956776 |
| 64 | Short foot (HP:0001773) | 2.02995054 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.01602260 |
| 66 | Status epilepticus (HP:0002133) | 2.00203680 |
| 67 | Preaxial hand polydactyly (HP:0001177) | 1.99424032 |
| 68 | Clumsiness (HP:0002312) | 1.97870887 |
| 69 | Labial hypoplasia (HP:0000066) | 1.96794579 |
| 70 | White forelock (HP:0002211) | 1.93013269 |
| 71 | Generalized hypotonia (HP:0001290) | 1.92059760 |
| 72 | Postural instability (HP:0002172) | 1.91431377 |
| 73 | Absent speech (HP:0001344) | 1.91123108 |
| 74 | Congenital hepatic fibrosis (HP:0002612) | 1.90781542 |
| 75 | Aganglionic megacolon (HP:0002251) | 1.86561825 |
| 76 | Scrotal hypoplasia (HP:0000046) | 1.86166451 |
| 77 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.86089024 |
| 78 | Broad foot (HP:0001769) | 1.82654191 |
| 79 | Reduced antithrombin III activity (HP:0001976) | 1.82094101 |
| 80 | Patchy hypopigmentation of hair (HP:0011365) | 1.82086114 |
| 81 | Abnormality of chromosome stability (HP:0003220) | 1.81611775 |
| 82 | Abnormality of DNA repair (HP:0003254) | 1.80781603 |
| 83 | Morphological abnormality of the middle ear (HP:0008609) | 1.79724115 |
| 84 | Narrow forehead (HP:0000341) | 1.77969794 |
| 85 | Postaxial hand polydactyly (HP:0001162) | 1.75998623 |
| 86 | Sleep apnea (HP:0010535) | 1.74798908 |
| 87 | Hypoplastic female external genitalia (HP:0012815) | 1.74217090 |
| 88 | Narrow nasal bridge (HP:0000446) | 1.73718264 |
| 89 | Abnormal biliary tract morphology (HP:0012440) | 1.73594159 |
| 90 | Oligohydramnios (HP:0001562) | 1.72631767 |
| 91 | Generalized tonic-clonic seizures (HP:0002069) | 1.72177300 |
| 92 | Increased corneal curvature (HP:0100692) | 1.71734864 |
| 93 | Keratoconus (HP:0000563) | 1.71734864 |
| 94 | Micropenis (HP:0000054) | 1.71067104 |
| 95 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.70285542 |
| 96 | Dyskinesia (HP:0100660) | 1.69780836 |
| 97 | Decreased central vision (HP:0007663) | 1.68446240 |
| 98 | Left ventricular hypertrophy (HP:0001712) | 1.68435949 |
| 99 | Acute necrotizing encephalopathy (HP:0006965) | 1.68211836 |
| 100 | Decreased muscle mass (HP:0003199) | 1.67908096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 6.85294317 |
| 2 | MARK1 | 3.65922477 |
| 3 | CASK | 3.50799683 |
| 4 | MAPK13 | 3.12423537 |
| 5 | WNK3 | 2.78336253 |
| 6 | CDK19 | 2.54140019 |
| 7 | PRKD3 | 2.25934622 |
| 8 | OBSCN | 2.25514584 |
| 9 | MAP3K9 | 2.21494473 |
| 10 | PHKG2 | 1.96698503 |
| 11 | PHKG1 | 1.96698503 |
| 12 | DYRK3 | 1.94777563 |
| 13 | NTRK3 | 1.87214711 |
| 14 | DYRK2 | 1.80651140 |
| 15 | MAP4K2 | 1.60391885 |
| 16 | PNCK | 1.60345463 |
| 17 | TNIK | 1.57349432 |
| 18 | ARAF | 1.54107087 |
| 19 | BMPR1B | 1.50051222 |
| 20 | BCR | 1.49665659 |
| 21 | PRKCG | 1.39307017 |
| 22 | MAP2K7 | 1.38939825 |
| 23 | TAF1 | 1.35636706 |
| 24 | MARK3 | 1.34116286 |
| 25 | LMTK2 | 1.31677670 |
| 26 | ZAK | 1.27768317 |
| 27 | CAMK1 | 1.27459190 |
| 28 | CSNK1G2 | 1.22275404 |
| 29 | SRPK1 | 1.21213760 |
| 30 | GRK1 | 1.20361649 |
| 31 | EIF2AK3 | 1.19837250 |
| 32 | OXSR1 | 1.14210547 |
| 33 | ADRBK2 | 1.13899924 |
| 34 | TLK1 | 1.11836571 |
| 35 | PLK4 | 1.07458295 |
| 36 | CSNK1G3 | 1.07152046 |
| 37 | EPHB2 | 1.06697908 |
| 38 | MINK1 | 0.98719008 |
| 39 | WEE1 | 0.98379850 |
| 40 | NTRK2 | 0.89468615 |
| 41 | KSR1 | 0.89230800 |
| 42 | BCKDK | 0.87871424 |
| 43 | NUAK1 | 0.86344736 |
| 44 | WNK4 | 0.85689197 |
| 45 | CSNK1A1L | 0.85602748 |
| 46 | CSNK1G1 | 0.85230176 |
| 47 | STK39 | 0.84827653 |
| 48 | PLK2 | 0.83852175 |
| 49 | PRKD2 | 0.81052272 |
| 50 | FRK | 0.80385335 |
| 51 | MUSK | 0.79804982 |
| 52 | PRKCQ | 0.75650861 |
| 53 | ERBB3 | 0.68536190 |
| 54 | BRD4 | 0.67570347 |
| 55 | PAK3 | 0.66597741 |
| 56 | CDC7 | 0.65238090 |
| 57 | RPS6KA2 | 0.63638909 |
| 58 | NEK2 | 0.63243449 |
| 59 | DYRK1A | 0.63204281 |
| 60 | RPS6KA4 | 0.62886564 |
| 61 | VRK1 | 0.62601628 |
| 62 | PLK1 | 0.60123357 |
| 63 | MOS | 0.58431812 |
| 64 | PKN1 | 0.58148620 |
| 65 | LATS1 | 0.57887043 |
| 66 | ABL2 | 0.57483834 |
| 67 | PRKACB | 0.56001854 |
| 68 | PRKCE | 0.53446628 |
| 69 | PBK | 0.53256831 |
| 70 | PRKCZ | 0.52452647 |
| 71 | CCNB1 | 0.52329004 |
| 72 | PRKD1 | 0.50912598 |
| 73 | PRKAA1 | 0.50472429 |
| 74 | MAP3K13 | 0.50178036 |
| 75 | CDK14 | 0.49635191 |
| 76 | PRKCI | 0.49307399 |
| 77 | CSNK1A1 | 0.49119913 |
| 78 | PRKCH | 0.48149372 |
| 79 | CSNK1D | 0.45622528 |
| 80 | MYLK | 0.45184773 |
| 81 | TRIM28 | 0.44989030 |
| 82 | PRKG1 | 0.44905331 |
| 83 | CDK5 | 0.44295475 |
| 84 | SGK494 | 0.42468902 |
| 85 | SGK223 | 0.42468902 |
| 86 | PRKACA | 0.41958750 |
| 87 | BRAF | 0.41869933 |
| 88 | EPHA3 | 0.40208890 |
| 89 | CAMK2A | 0.39726779 |
| 90 | NME1 | 0.38647886 |
| 91 | ERBB2 | 0.38593488 |
| 92 | INSRR | 0.38550606 |
| 93 | VRK2 | 0.37587615 |
| 94 | AKT2 | 0.32869353 |
| 95 | CDK11A | 0.32368233 |
| 96 | PIK3CA | 0.32292304 |
| 97 | CSNK1E | 0.31020058 |
| 98 | ROCK1 | 0.30228753 |
| 99 | STK16 | 0.29709982 |
| 100 | TAOK1 | 0.29431301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.71971613 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 2.76860758 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.67244396 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.35380788 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.27630785 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.18659030 |
| 7 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.05800023 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96865094 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.91601565 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 1.90043898 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.88242265 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 1.87759294 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.84859859 |
| 14 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.75681357 |
| 15 | Basal transcription factors_Homo sapiens_hsa03022 | 1.74148842 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67204119 |
| 17 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.66673998 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.63422524 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.61235782 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.54783235 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.50700433 |
| 22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.46797007 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.42300402 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.40199906 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.39201662 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36628390 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.35006040 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.33380172 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33336518 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27709263 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.26530921 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.25639514 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.25338121 |
| 34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.24842110 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.17382183 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12684622 |
| 37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.12515582 |
| 38 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.10388391 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.07829094 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.06980695 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.06935154 |
| 42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04948985 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00274506 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00012096 |
| 45 | Purine metabolism_Homo sapiens_hsa00230 | 0.98906147 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95442719 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94446626 |
| 48 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93644456 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93578591 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 0.92131665 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.89282161 |
| 52 | Ribosome_Homo sapiens_hsa03010 | 0.88417907 |
| 53 | Taste transduction_Homo sapiens_hsa04742 | 0.87997462 |
| 54 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87682212 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87074962 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86572038 |
| 57 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.85952136 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84924348 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84246291 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 0.81615826 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80256561 |
| 62 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78852190 |
| 63 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.78329464 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.77785178 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.77456406 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76720290 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75711134 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.74232665 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73014538 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.69753939 |
| 71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69561903 |
| 72 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.69097233 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68481913 |
| 74 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66277481 |
| 75 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66174965 |
| 76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64633964 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63173248 |
| 78 | Mismatch repair_Homo sapiens_hsa03430 | 0.59679712 |
| 79 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59638805 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.58733651 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57808050 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57718903 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55967107 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55345916 |
| 85 | Insulin secretion_Homo sapiens_hsa04911 | 0.55313065 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54651531 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53701189 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.53350101 |
| 89 | Spliceosome_Homo sapiens_hsa03040 | 0.53280257 |
| 90 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51500139 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.49582559 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48404634 |
| 93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48177267 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47236884 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46667832 |
| 96 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46144318 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45741984 |
| 98 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45471939 |
| 99 | Base excision repair_Homo sapiens_hsa03410 | 0.44779619 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44627696 |

